Cambridge Healthtech Institute’s 3rd Annual

RNA as a Drug Target

Using Small Molecules and Oligos to Modulate RNA for Covid and Other Disease Indications

September 28-29, 2021

 

The SARS-CoV-2 pandemic has brought RNA to the forefront as a target for therapeutic and diagnostic development. Now there is an increased focus on understanding the structure and function of the various RNA moieties present in the cell, the proteins they interact with and the role they play in infection, inflammation and other disease conditions. There is also increased interest in finding small molecules and oligos that can modulate the RNA function to get the desired biological outcome. However, defining which RNA to target and how/where to target it is not easy, as some of the disease mechanisms and RNA ligand binding sites are not very well understood. Challenges also exist in terms of specificity, selectivity, and safety of these molecules when targeting RNA in vivo. Cambridge Healthtech Institute's conference on RNA as a Drug Target will highlight some of the innovative approaches being pursued to target RNA for therapeutic intervention.

 

Who should attend: Scientists in Discovery Chemistry, Medicinal Chemistry, Biology, Assay Development, Screening, ADME/PKPD, Toxicology

 

Coverage will include, but is not limited to:

 

  • Tools for identifying the right RNA target for therapeutic intervention
  • Determining the structural and physicochemical constraints for RNA-ligand interactions
  • Strategies for characterization and lead optimization of RNA-targeting molecules
  • Bioanalytical/phenotypic screening for identifying and quantifying RNA binding
  • Optimizing the efficacy and safety of candidates for clinical development
  • Tackling concerns surrounding specificity, stability, biodistribution and pharmacodynamics
  • Addressing issues related to drug delivery and safety

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is March 29, 2021.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286

Email: reymael@healthtech.com


Submit a Speaker Proposal